Review
Published on 05 Nov 2025
Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
- 430 views
Review
Published on 05 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Published on 05 Nov 2025
in Translational and Clinical Endocrinology
Original Research
Published on 05 Nov 2025
in Public Mental Health
Systematic Review
Published on 05 Nov 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 05 Nov 2025
in Hematologic Malignancies
Original Research
Published on 05 Nov 2025
in Immunological Tolerance and Regulation
Original Research
Published on 05 Nov 2025
in Pediatric Oncology
Review
Published on 05 Nov 2025
in Cancer Endocrinology
Review
Published on 05 Nov 2025
in Adrenal Endocrinology
Review
Published on 05 Nov 2025
in Translational and Clinical Endocrinology
Original Research
Published on 05 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 05 Nov 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 05 Nov 2025
in Public Health Education and Promotion
Systematic Review
Published on 05 Nov 2025
in Stroke
Review
Published on 05 Nov 2025
in Diabetes: Molecular Mechanisms
Original Research
Published on 05 Nov 2025
in Surgical Oncology